Members
The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.
The WGND membership rests with individuals, not institutions. Thus, the WGND has no "lead agency" and is not dominated by any institution or group of institutions. Members represent the private and public sectors and come from diverse geographical locations.
Apply Now Learn More View Core GroupCurrent Members
Name | Organization | Country |
---|---|---|
Kampasati Satyanarayana | Yuvabharath Society | India |
Sang Nae Cho | Yonsei University College of Medicine | South Korea |
Christian Lienhardt | World Health Organization (WHO) | Senegal |
Malgosia Grzemska | World Health Organization (WHO) | Switzerland |
Kobina Bosumtwi Dadzie | Wiljok Childaid and Health Organization | Ghana |
Philip Onyebujoh | WHO Regional Office for Africa | Zimbabwe |
Tamari Trapaidze | Welfare Foundation | Georgia |
Carl Nathan | Weill Cornell Medical College | United States |
Kyu Rhee | Weill Cornell Medical College | United States |
Dirk Schnappinger | Weill Cornell Medical College | United States |
Astrid Van der Sar | VU University Medical Center | Netherlands |
Tiansheng Wang | Vertex Pharmaceuticals | United States |
Michael Cynamon | VAMC, SUNY, Upstate Medical University | United States |
Shashi Kant | UT Southwestern Medical Center | United States |
Norbert Heinrich | Universtiy of Munich / PanACEA | Germany |
David Sherman | University of Washington | United States |
Bavesh Kana | University of the Witwatersrand/National Health Laboratory Service | South Africa |
Andreas Diacon | University of Stellenbosch | South Africa |
Marcio Dias | University of Sao Paulo | Brazil |
Bernard Fourie | University of Pretoria | South Africa |
Anthony Baughn | University of Minnesota | United States |
Sylvie Garneau-Tsodikova | University of Michigan | United States |
Christopher Sassetti | University of Massachusetts Medical School | United States |
Parameshwar Makam | University of KwaZulu-Natal | South Africa |
Oleg Tsodikov | University of Kentucky | United States |
Ute Muh | University of Iowa | United States |
Jonathan Blackburn | University of Cape Town | South Africa |
Payam Nahid | University of California, San Francisco | United States |
Gustavo E. Velásquez | University of California, San Francisco | USA |
Yossef Av-Gay | University of British Columbia | Canada |
Arun Kumar Mishra | University of Birmingham | United Kingdom |
Thomas Dick | University in New Jersey UMDNJ-New Jersey Medical School | United States |
Ibrahim Abubakar | University College London, MRC Clinical Trials Unit | United Kingdom |
Aboubacar Sidiki Daffe | Université Cheikh Anta DIOP | Senegal |
Mario Raviglione | Università degli Studi di Milano | Switzerland |
Amy Bloom | United States Agency for International Development (USAID) | United States |
Joel Freundlich | UMDNJ - New Jersey Medical School | United States |
Joshua Wamboga | Uganda Network of AIDS Service Organisations (UNASO) | Uganda |
Valerie Mizrahi | UCT-Institute of Infectious Disease and Molecular Medicine | South Africa |
Andrew Vernon | U.S. Centers for Disease Control and Prevention (CDC) | United States |
P. R. Narayanan | Tuberculosis Research Centre, Chennai (retired) | India |
Ronan O'Toole | Trinity College Dublin | Ireland |
Erica Lessem | Treatment Action Group | United States |
Mark Harrington | Treatment Action Group | United States |
Kristina Wallengren | THINK | South Africa |
Sanjib Bhakta | The Institute of Structural and Molecular Biology, Birkbeck, University of London | United Kingdom |
William Chamberlin | Texas Tech University Health Sciences Center | United States |
Jeffery Cirillo | Texas A&M Health Science Center | United States |
Dalene von Delft | TB Proof | South Africa |
Asghar Arif | TB Association Charsadda Pak | Pakistan |
Cherise Scott | TB Alliance | United States |
Rajneesh Taneja | TB Alliance | United States |
Anna Upton | TB Alliance | United States |
Takushi Kaneko | TB Alliance | United States |
Frances Pappas | TB Alliance | United States |
Christo van Niekerk | TB Alliance | South Africa |
Melvin Spigelman | TB Alliance | United States |
Klaus Reither | Swiss Tropical and Public Health Institute | Tanzania |
Gill Black | Sustainable Livelihoods Foundation | South Africa |
Edward Berry | SUNY Upstate Medical University | United States |
Gerhard Walzl | Stellenbosch University | South Africa |
Amina Jindani | St. George's, University of London | United Kingdom |
KR John | SRM Medical College | India |
Prasad Pasam | Shar Technologies Group | India |
Carol Nacy | Sequella, Inc. | United States |
Leo Einck | Sequella, Inc. | United States |
Jacques Grosset | Scientist | France |
Fernando Pavan | Sao Paulo State University, UNESP, Brazil | Brazil |
Victoria Kasprowicz | SANTHE | South Africa |
John Szumowski | Santa Clara Valley Medical Center | United States |
Alexandra Carreau | Sanofi-Adventis R&D | France |
Florence Bordon-Pallier | Sanofi | France |
Isabelle Cieren-Puiseux | Sanofi | France |
Charles Wells | Sanofi | United States |
Brigitte Demers | Sanofi | France |
Didier Leboulleux | Sanofi | France |
Doris Rouse | RTI International | United States |
Santiago Ramón García | Research Agency of Aragon (ARAID) | Spain |
Michaela Nielsen | Regulatory Affairs Consultant | United States |
Bob Goldman | RCG Consulting | United States |
Bolin Geng | Ra Pharma | United States |
Dario Scaramuzzi | R-Evolution Group EEIG | Italy |
Daniel Zollinger | QareFree | Netherlands |
Khadar Bhatcha | PSG College of Pharmacy | India |
Teto Fondacaro Mamona | Programme National de Lutte Contre la Tuberculose | Democratic Republic Of Congo (Zaire) |
Nelson Otwoma | Positive Familes Network (+FN) | Kenya |
Chris Dippel | Peloton Partnering, SP | United States |
Claire Wingfield | PATH | United States |
Valerie Flore Donkeng Donfack | Pasteur Center in Cameroon | Cameroon |
Edward Nardell | Partners in Health | United States |
Martin Johan Boeree | PanACEA Consortium and the Radboud University Nijmegen Medical Centre | Netherlands |
Lawrence Geiter | Otsuka Pharmaceutical Company | United States |
Manjunatha Ujjini | Novartis Institute for Tropical Diseases | Singapore |
Avishek Anant | Novartis | India |
Roberto Salvino | No affiliation | Philippines |
Sandeep Saluja | No affiliation | India |
Daniela Jabes | NeED Parma | Italy |
Abdifetah Ibrahim Omer | National TB Programme Somalia | Somalia |
Htay Lwin | National TB Program, Myanmar | Myanmar (Burma) |
Basharat Khan | National TB Control Programme | Pakistan |
Zahoor Ahmed | National TB Control Programme | Pakistan |
Andriy Dudnyk | National Medical University of Vinnytsia, Ukraine | Ukraine |
Liyanage Perera | National Institutes of Health (NIH) | United States |
Helena Boshoff | National Institutes of Health (NIH) | United States |
Rogelio Hernandez Pando | National Institute of Medical Sciences and Nutrition, Mexico | Mexico |
Jim Boyce | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Laura Via | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Francisco Leyva | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Barbara Laughon | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Sharon Williams | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Gail Tauscher | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Mamodikoe Makhene | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Marina Protopopova | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Clifton Barry | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
Shekhar Mande | National Centre for Cell Science | India |
Nino Lomtadze | National Center for Tuberculosis and Lung Diseases | Georgia |
Nelly Solomonia | National Center for Tuberculosis and Lung Diseases | Georgia |
Asaad Khalid Ahmed | National Center for Research | Sudan |
Sonja Henne | MSF | Tunisia |
Dhanji Rajani | Microcare Laboratory | India |
Maggie McCammon | Michigan Economic Development Corporation | United States |
Tarek Aboul-Fadl | Medicinal Chemistry, Assiut University | Egypt |
David McNeeley | Medical Service Corportation International (MSCI) | United States |
Renaud Boulanger | McGill University | Canada |
Prasit Palittapongarnpim | Mahidol University | Thailand |
Rajender Kamboj | Lupin Limited | India |
Galyna Kutsyna | Luhansk State Medical University | Ukraine |
Michael Hoelscher | Ludwig-Maximilians-University | Germany |
Richard White | London School of Hygiene and Tropical Medicine | United Kingdom |
Philip Hipskind | Lgenia | United States |
Sang Jae Kim | Korean Institute of Tuberculosis | South Korea |
James Love | Knowledge Ecology International (KEI) | United States |
Martin Graham | KinderPharm | United States |
Steve Wandiga | KEMRI/CDC | Kenya |
Oren Zimhony | Kaplan Medical Center, The School of Medicine Hebrew University | Israel |
Sergey Koren | JSC Pharmasyntez | Russia |
Anil Koul | Johnson and Johnson | Belgium |
Petros Karakousis | Johns Hopkins University School of Medicine | United States |
Shichun Lun | Johns Hopkins University School of Medicine | United States |
Richard Chaisson | Johns Hopkins University Center for TB Research | United States |
Ying Zhang | Johns Hopkins University | United States |
Gyanu Lamichhane | Johns Hopkins University | United States |
Eric Nuermberger | Johns Hopkins University | United States |
William Bishai | Johns Hopkins School of Medicine | United States |
Tado Shimao | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
Noroi Doi | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
Koen Andries | Janssen | Belgium |
Chris Edlin | iThemba Pharmaceuticals | South Africa |
Roger Moses | iThemba Pharmaceuticals | United Kingdom |
Dorothy Odhiambo | International Community of Women Living with HIV in Kenya ( ICW-K) | Kenya |
Kanury Rao | International Centre for Genetic Engineering & Biotechnology-New Delhi | India |
Hugo Cesar Gramajo | Instituto de Biologia Molecular y Celular de Rosario | Argentina |
Scott Franzblau | Institute for Tuberculosis Research, University of Illinois at Chicago | United States |
Kevin Pethe | Institut Pasteur-Korea | South Korea |
Nicolas Willand | Institut Pasteur Lille | France |
Stewart Cole | Institut Pasteur | Switzerland |
Pere-Joan Cardona | Institut Germans Trias i Pujol (IGTP) | Spain |
Iain Old | Innovative Medicines for TB (iM4TB) | Switzerland |
Gail Cassell | Infectious Disease Research Institute (IDRI) | United States |
Allen Casey | Infectious Disease Research Institute (IDRI) | United States |
Tanya Parish | Infectious Disease Research Institute (IDRI) | United States |
Brian Robertson | Imperial College London | United Kingdom |
Ann Ginsberg | IAVI | United States |
James Frincke | Hollis Eden Pharmaceuticals | United States |
Polly Clayden | HIV i-Base | United Kingdom |
Matthew Price | Harvard School of Public Health | United States |
Carole Mitnick | Harvard Medical School | United States |
Alick Chimpimo Makiyi | Grassroots Movement for Health and Development (GMHD) | Malawi |
Muhammad Farooq | Government of Pakistan | Pakistan |
Samir Roy | Government Medical College, Bhavnagar | India |
Bonita Mangura | Global TB Institute at UMDNJ | United States |
Stephen Matlin | Global Forum for Health Research | Switzerland |
Christopher Cooper | Global Alliance for TB Drug Development (TB Alliance) | United States |
Lluís Ballell | GlaxoSmithKline Tres Cantos | Spain |
Robert Bates | GlaxoSmithKline | Spain |
Oscar Della Pasqua | GlaxoSmithKline | United Kingdom |
David Barros | GlaxoSithKline | Spain |
Nii Nortey Hanson-Nortey | Ghana Health Service | Ghana |
Mohammad Hassan Mashori | Fundamental Human Rights & Rural Development Association (FHRRDA) | Pakistan |
Doug Lowrie | Fudan University's Shanghai Public Health Clinical Center | China |
Xuelian Zhang | Fudan University | China |
Jing Bao | Frontier Biotechnologies, LLC | United States |
Maria Freire | Foundation for NIH | United States |
Christine Sizemore | Fogarty International Center at NIH | United States |
Carol Dukes Hamilton | Family Health International | United States |
Wim Vandevelde | European AIDS Treatment Group (EATG); Community Representative | South Africa |
Jurriaan de Steenwinkel | Erasmus MC | Netherlands |
Yap Boum II | Epicentre/MSF | Uganda |
Kenneth Castro | Emory University | United States |
Neeraj Dhar | École Polytechnique Fédérale de Lausanne (EPFL) | Switzerland |
Todd Waldman | Easton Associates | United States |
Anneke Hesseling | Desmond Tutu TB Centre | South Africa |
Tanjore Balganesh | CSIR-OSDD | India |
Ravishankar Ramachandran | CSIR-Central Drug Research Institute, Lucknow, India | India |
Hulda Swai | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
Boitumelo Semete | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
Brian VanderVen | Cornell University | United States |
David Russell | Cornell University | United States |
Albert Makone | Community Representative; Global Fund (local) | Zimbabwe |
Josef Jampilek | Comenius University | Slovakia |
Anne Lenaerts | Colorado State University | United States |
Mary Jackson | Colorado State University | United States |
Mary Ann de Groote | Colorado State University | United States |
Diane Ordway | Colorado State University | United States |
Barry Bunin | Collaborative Drug Discovery | United States |
Regina Osih | Clinton Health Access Initiative | South Africa |
Shreemanta Parida | Clinical Scientist | India |
Masaji Okada | Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center | Japan |
Robert Husson | Children's Hospital Boston/Harvard Medical School | United States |
Martin Dolezal | Charles University in Prague, Faculty of Pharmacy in Hradec Kralove | Czech Republic |
Sidharth Chopra | Central Drug Research Institute, Lucknow | India |
Benson Muriuki | Center for the Empowerment Of The Local Herbalist-Celoh Kenya | Kenya |
Jerome Zeldis | Celgene | United States |
Shashank Gupta | Brown University | United States |
C. Robert Horsburgh | Boston University School of Public Health | United States |
Juan David Guzman | Birkbeck College | United Kingdom |
Marc Gitzinger | BioVersys AG | Switzerland |
Yadav Prasad Joshi | Biodyss and Journal Infection in Developing Countries | France |
Khisimuzi Mdluli | Bill and Melinda Gates Medical Research Institute | United States |
Debra Hanna | Bill and Melinda Gates Foundation | United States |
Omar Vandal | Bill and Melinda Gates Foundation | United States |
Peter Warner | Bill and Melinda Gates Foundation | United States |
Cathy Bansbach | Bill & Melinda Gates Foundation | United States |
Jan Gheuens | Bill & Melinda Gates Foundation | United States |
Ken Duncan | Bill & Melinda Gates Foundation | United States |
Tawanda Gumbo | Baylor University | United States |
Martin Springsklee | Bayer Healthcare | United States |
Christopher Locher | Baxalta | United States |
Simon Tiberi | Barts Healthcare NHS Trust | United Kingdom |
Gary Horwith | BARDA | United States |
Robert Wallis | Aurum Institute | South Africa |
Hiromu Kawakubo | Asahi Kasei Chemicals Corporation | Japan |
Ahmadul Khan | Ahmadul Hasan Khan | Bangladesh |
Joan A. Cayla | Agència de Salut Pública de Barcelona | Spain |
Kolawole Ekanoye | Advocates for Health and Development Initiative | Nigeria |
Heinz Moser | Achaogen | United States |
Rick O'Brien | Switzerland | |
Gilla Kaplan | United States |
New Members
The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.
Apply NowQuestions? Contact Us